Recently, AceCTMS, the clinical trial management system under AceTeamwork, has rolled out a major intelligent version upgrade. Addressing industry pain points faced by pharmaceutical companies, CROs, SMOs and clinical research institutions — such as scattered multi-center management, heavy manual data entry, unclear costs and profits, complex reconciliation and settlement, high GCP audit requirements, and difficult clinical R&D expense aggregation — the new AceCTMS integrates the MCP smart ecosystem, AI automation, fine-grained permissions, EDC data interoperability, full-cost accounting and compliance audit capabilities to build a fully closed-loop, readily deployable digital clinical trial management platform for the biopharmaceutical industry.
This upgrade also comes with a refreshed official website, optimized UI visual experience, newly launched product feature video walkthroughs and a benchmark customer case section, building a one-stop online self-service system. Enterprises can complete product research, capability assessment and free trial applications online, or book a dedicated pre-sales demo to quickly finish product deployment evaluation.
Product page: https://www.aceteamwork.com/products/acectms
AceCTMS delivers closed-loop management across the entire clinical trial lifecycle — initiation → planning → execution → settlement → close-out — and builds an integrated full-cost accounting system covering timesheet collection, expense control, external payment aggregation and actual-cost settlement. It comprehensively meets GCP compliance, routine monitoring, and internal and external audit traceability requirements, and now deeply serves several leading clinical research institutions such as Borun Sunshine,澎立生物 and Sinovac Biotech.
1. Full AI Implementation: MCP Protocol Empowers Efficient Clinical Workload Reduction
The new AceCTMS is among the first to implement the MCP (Model Context Protocol), enabling AI agent system integration. It can autonomously handle routine clinical work such as project data queries, daily data entry, risk screening and data report statistics, completely transforming the traditional manual operation model and achieving intelligent, autonomous and efficient clinical trial management.
Focusing on reducing the burden of frontline clinical operations, the system implements a range of practical AI features to efficiently solve industry pain points such as cumbersome document entry, error-prone data and delayed ledger updates. With voice entry capabilities, CRCs and CRAs can directly record daily visits and monitoring work by voice, quickly completing timesheet entry and more, greatly reducing manual entry workload. It also supports photographing and uploading lab reports for recognition, using OCR smart technology to automatically capture information, enter data and archive materials, avoiding manual entry errors at the source.
2. Fine-Grained Business and Permission Control with Deep EDC Data Interoperability
Given the industry characteristics of clinical trials — multiple participants, multi-role collaboration and strict separation of responsibilities — the system builds a comprehensive multi-role, fine-grained permission framework that precisely adapts to tiered control for sponsors, project managers, CRAs, PIs, CRCs, research institutions, finance and all other positions, achieving clear responsibilities, data isolation and full operation traceability, fully in line with clinical compliance control standards.
Meanwhile, the platform achieves deep two-way integration with EDC systems. Subject information, follow-up records and trial query lists can all be synchronized in real time in both directions, completely breaking the industry pain points of data fragmentation, duplicate entry and data inconsistency between CTMS and EDC systems. It supports linking timesheet entries directly to corresponding follow-up items and monitoring work, achieving same-source interoperability of business, timesheet and progress data. Every work record and every timesheet entry can be precisely traced back to its corresponding clinical business scenario.
3. Full-Process GCP Compliance Control, Adapted to IPO Audits, High-Tech Certification and R&D Super-Deductions
AceCTMS fully aligns with biopharmaceutical GCP compliance management standards, covering core capabilities such as subject screening and enrollment, full-course follow-up management, SAE/SUSAR reporting, multi-center monitoring, project document archiving, deviation control and full-process audit trails. All operations, data changes and approval processes are fully logged, traceable and verifiable, fully meeting the verification requirements of routine monitoring, corporate internal audits and third-party external audits.
Focusing on the core development and tax needs of listed pharmaceutical companies, pre-IPO enterprises and high-tech enterprises, the system builds a complete compliance evidence chain for clinical R&D, automatically aggregating all R&D investment data such as clinical trial labor hours, outsourced services, consumable expenditures, equipment depreciation and project travel. It precisely adapts to IPO audit verification, high-tech enterprise certification and re-certification, and R&D expense super-deduction policy standards, and can export standardized R&D expense auxiliary ledgers and full audit ledgers with one click, helping enterprises standardize clinical R&D expense aggregation processes, efficiently pass various compliance reviews, fully enjoy tax incentive policies and unlock tax-saving benefits.
4. Integrated Full-Cost Accounting with Smart Actual-Cost Settlement to Precisely Control Project Profit
Compared with the limitations of traditional CTMS that focus heavily on trial progress management, AceCTMS connects the entire business and finance chain, building an integrated full-cost accounting system covering labor costs, expense reimbursement, external payments and actual-cost settlement, fully achieving transparent clinical project costs and quantifiable profits.
The system adapts to mainstream settlement models in the clinical industry, supporting multiple settlement rules such as cost-plus, fixed rate and per-person-day pricing. It can automatically generate settlement details based on real timesheets, actual expenses and project progress, and supports online reconciliation and verification among finance, PMs and partners. It effectively solves the pain points of cumbersome reconciliation, long settlement cycles, unclear costs and hard-to-count profits in clinical projects, helping pharmaceutical companies, CROs and SMOs precisely control budgets, cut redundant costs and improve overall project profitability.
5. Seamless Integration Across the Ecosystem, Lowering Deployment Barriers and Boosting Organization-Wide Efficiency
AceCTMS can also seamlessly connect with 30+ mainstream office and finance platforms such as WeCom, Feishu, DingTalk, SAP, Kingdee and Yonyou, automatically synchronizing organizational structure, personnel, attendance and financial cost data, enabling single sign-on, message push, approval linkage and timesheet data interoperability, and breaking down enterprise data barriers.
Clinical staff no longer need to switch between multiple systems — they can complete full-process business operations from their daily office workspace, effectively lowering system deployment and organization-wide usage barriers and helping enterprises quickly implement digital clinical management.
With 16 years of deep expertise in compliance and project digitalization, AceTeamwork is deeply engaged in the biopharmaceutical clinical track. Integrating six core capabilities — the MCP smart ecosystem, AI automation, fine-grained permissions, EDC data interoperability, GCP compliance auditing and full-cost accounting — it provides integrated clinical digital solutions for pharmaceutical companies, CROs, SMOs and clinical research institutions, truly achieving: clinical processes under control, costs and profits clearly calculated, and GCP compliance guaranteed!